Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear increased » linear increase (Expand Search), linear decrease (Expand Search), levels increased (Expand Search)
larger decrease » marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear increased » linear increase (Expand Search), linear decrease (Expand Search), levels increased (Expand Search)
larger decrease » marked decrease (Expand Search)
-
921
-
922
-
923
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
924
-
925
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
926
-
927
-
928
-
929
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
930
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
931
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
932
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
933
-
934
-
935
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
936
Scatter plot for linearity.
Published 2025“…There was no significant association between students’ gerontology knowledge and self-efficacy. …”
-
937
-
938
-
939
Flowchart of the screening process.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
-
940
Result of the AMSTAR-2 assessments.
Published 2025“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”